𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Boceprevir and Telaprevir in the Management of Hepatitis C Virus-Infected Patients

✍ Scribed by Butt, A. A.; Kanwal, F.

Book ID
121720971
Publisher
University of Chicago Press
Year
2011
Tongue
English
Weight
783 KB
Volume
54
Category
Article
ISSN
1058-4838

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Characterization of resistance to the pr
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients
✍ Simone Susser; Christoph Welsch; Yalan Wang; Markus Zettler; Francisco S. Doming πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 543 KB

Boceprevir is a hepatitis C virus (HCV) nonstructural protein (NS) 3/4A protease inhibitor that is currently being evaluated in combination with peginterferon alfa-2b and ribavirin in phase 3 studies. The clinical resistance profile of boceprevir is not characterized in detail so far. The NS3 protea